Access to the full text of this article requires a subscription.
  • If you are a subscriber, please sign in 'My Account' at the top right of the screen.

  • If you want to subscribe to this journal, see our rates

Journal of the American Academy of Dermatology
Volume 38, n° 6
pages 979-982 (juin 1998)
Doi : 10.1016/S0190-9622(98)70163-X
An assessment of topical and oral prescription and over-the-counter treatments for head lice

Craig G. Burkhart, MSPH, MD a, b, Craig N. Burkhart b, Kristiina M. Burkhart b
a Department of Medicine, Medical College of Ohio at Toledo, and Ohio University College of Osteopathic Medicine Toledo, Ohio 
b Department of Biology, University of Toledo. Toledo, Ohio 


A plethora of head lice cases that require optimal therapeutic assessments are developing in elementary schools. Over-the-counter therapies continue to be the mainstream solution for most cases of pediculosis capitis, but the onset of resistant cases dictates a review of available treatment modalities. The increased efficacy of prescription drugs, namely topical 5% permethrin and oral ivermectin, underline the expanding role that physicians will serve in the eradication of head lice in our communities. (J Am Acad Dermatol 1998;38:979-82.)

The full text of this article is available in PDF format.

 Reprint requests: Craig G. Burkhart, MSPH, MD, 5600 Monroe St, Suite 106B, Sylvania, OH 43560.
 0190-9622/98/$5.00 + 0   16/1/89791

Top of the page

© 1998  American Academy of Dermatology, Inc. Published by Elsevier Masson SAS@@#104157@@